AMOEBA (EPA:ALMIB) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
AMOEBA

BRIEF

published on 11/26/2025 at 18:05, 8 days 12 hours ago

Amoéba is organizing a video conference to unveil its progress

AMOEBA Biocontrol Vidéo Conférence Trade Agreements Strategy 2026
BRIEF

published on 11/20/2025 at 18:05, 14 days 12 hours ago

Amoéba announces a video conference for investors on December 1, 2025

AMOEBA Investors Biocontrol Vidéo Conférence Strategy 2026
BRIEF

published on 11/18/2025 at 08:05, 16 days 22 hours ago

Innovation in crop protection: Syngenta and Amoéba collaborate

Syngenta Biocontrol Cereals Amoéba SA Amoeba Willaertia
PRESS RELEASE

published on 11/18/2025 at 08:00, 16 days 22 hours ago

A natural breakthrough in protecting cereals and field crops // Syngenta and Amoeba SA to develop and commercialize biocontrol solutions for EU and UK
Syngenta and Amoéba partner to develop bio-fungicide for cereals, combating fungal diseases. Planned agreement aims to enhance biological crop protection and sustainability in EU and UK markets

AMOEBA Syngenta Bio-fungicide Cereal Crops Biological Innovation
BRIEF

published on 10/29/2025 at 08:05, 1 month 6 days ago

Amoéba: Positive Results of the 2025 Vine Trials

AXPERA Copper Reduction Viticultural Trials Mildew Commercialization 2026
PRESS RELEASE

published on 10/29/2025 at 08:00, 1 month 6 days ago

Amoéba presents the 2025 results of its vineyard trial campaign: AXPERA confirms its effectiveness against downy mildew and its strong potential to significantly reduce copper use
Amoéba presents 2025 vineyard trial results confirming AXPERA's efficacy against downy mildew. AXPERA's performance in real conditions and response to French regulatory framework highlighted. Market authorization process and commercial launch details shared

AMOEBA Regulatory Framework Market Authorization AXPERA Vineyard Trial
BRIEF

published on 10/24/2025 at 18:05, 1 month 11 days ago

Amoéba Publishes its Half-Yearly Financial Report

AMOEBA Financial Report Biocontrol Cosmetic Patented Amoebas
PRESS RELEASE

published on 10/24/2025 at 18:00, 1 month 11 days ago

Amoéba: Publication of the half-year financial report as of June 30, 2025
Amoéba announces the availability of its half-year financial report for the period ending June 30, 2025, filed with the French Financial Markets Authority. The report can be accessed on the company's website

AMOEBA French Financial Markets Authority Half-year Financial Report GreenTech Microbiological Solutions
BRIEF

published on 10/20/2025 at 18:35, 1 month 15 days ago

AXPERA awarded for its innovation in biocontrol

AMOEBA Innovation Biocontrol Environment AXPERA
PRESS RELEASE

published on 10/20/2025 at 18:30, 1 month 15 days ago

AXPERA named biocontrol solution of the year 2025 // Amoeba's anti-fungal innovation wins the Gold Award at the 2025 Bernard Blum Awards
Amoéba wins prestigious Bernard Blum Gold Medal for innovation in biocontrol with AXPERA, a natural microbiological solution based on amoebae, offering plant protection against fungal diseases. Award highlights Amoéba's excellence in sustainable agriculture

AMOEBA Sustainable Agriculture Biocontrol AXPERA Bernard Blum Gold Medal

Accesswire

Published on 12/05/2025 at 02:35, 3 hours 35 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 3 hours 40 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 10 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 5 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 10 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 2 hours 39 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 19 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 44 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 55 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 59 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 12 hours 10 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 25 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 26 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 9 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE